| Literature DB >> 18428327 |
Abstract
The first half of this unit discusses the two main approaches to developing genetically engineered mouse models of human disease (i.e., transgenesis and gene targeting). The experimental steps for each method are discussed. Potential pitfalls, advantages, and limitations are also addressed. The second half of the unit describes two mouse models of hypertrophic cardiomyopathy, which illustrate the value of studying such models of human disease. The first half of this unit discusses the two main approaches to developing genetically engineered mouse models of human disease.Entities:
Mesh:
Year: 2002 PMID: 18428327 DOI: 10.1002/0471142905.hg1502s32
Source DB: PubMed Journal: Curr Protoc Hum Genet ISSN: 1934-8258